Tag: lecanemab donanemab new therapies

Blood Biomarkers and AI Imaging Reshape the Path to Earlier Alzheimer’s Diagnosis, Experts at Mahajan Imaging & Labs Say

Experts including Dr. Vinit Suri (Apollo Hospital), (Padma Shri) Dr. Harsh Mahajan, Dr. Shelly Mahajan, and Dr. Ritu Verma discussed the integration of pTAU217/βAmyloid1‑42 blood biomarker testing, AI‑enabled MRI, and FDG PET with clinical assessment.